Our data showed that the proportion of non-exhausted T cells expressing Tim-3-CD8+, CTLA4-CD8+ and PD-1-CD8+ in ALK-positive NSCLC was lower than that in EGFR/KRAS-positive NSCLC. This evidence concerns the gene KRAS and non-small cell lung carcinoma.